Eli Lilly EVP Adrienne Brown Reports RSU Settlement and Tax Withholding
ELI LILLY & Co
Subscribe to track LLY
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
ELI LILLY & CO ($LLY) | FORM 4 FILING
Insider: Brown Adrienne S (EVP, President LLY Imm)
Filing Date: 2026-11-03 | Transaction Date: 2026-11-01
-------------------------------------------------------
Transaction: Tax Withholding (Code F)
Shares: 1,098.656 @ $1,417.54
Total Value: $1,557,388.83
Resulting Ownership: 9,893.923 shares (Direct)
Significance: Low (Routine RSU Vest & Tax Withholding)
Comprehensive Analysis
Executive Summary
On November 3, 2026, Eli Lilly and Company ($LLY) officer Adrienne S. Brown, Executive Vice President and President of Lilly Immunology, filed a Form 4 detailing restricted stock unit (RSU) vesting and associated tax withholding transactions occurring on November 1, 2026.
Transaction Details
-
RSU Conversion (Code M):
- Derivative: 2,530 Restricted Stock Units converted into 2,530 shares of common stock at $0.00.
- Status: Post-exercise RSU balance is 0.
-
Shares Withheld for Taxes (Code F):
- Shares Withheld: 1,098.656 shares of Common Stock.
- Valuation Price: $1,417.54 per share.
- Total Withholding Value: approximately $1,557,388.83.
- Ending Direct Ownership: 9,893.923 shares.
Market and Trading Assessment
- Nature of Transaction: Routine equity compensation vesting and mandatory tax liability settlement.
- Significance: Low. The disposition represents statutory tax withholding rather than discretionary open-market selling or a shift in executive sentiment.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.